Financials

News Discussions Technicals Seasonals

RIZE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Rize Oncology, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

RIZE has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company